Association of HbA1c Variability with Vibrating Perception Threshold in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study

References

• Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020:m997. doi:10.1136/bmj.m997
   PubMedGoogle Scholar
• Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154. doi:10.2337/dc16-2042
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–S27. doi:10.2337/dc18-S002
   PubMed Web of Science ®Google Scholar
• Jung J, Kim MG, Kang YJ, et al. Vibration perception threshold and related factors for balance assessment in patients with type 2 diabetes mellitus. Int J Environ Res Public Health. 2021;18(11):6046. doi:10.3390/ijerph18116046
   PubMed Web of Science ®Google Scholar
• Ponirakis G, Odriozola MN, Odriozola S, et al. NerveCheck for the detection of sensory loss and neuropathic pain in diabetes. Diabetes Technol Ther. 2016;18(12):800–805. doi:10.1089/dia.2016.0279
   PubMed Web of Science ®Google Scholar
• Skrha J, Soupal J, Skrha JJ, et al. Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord. 2016;17(1):103–110. doi:10.1007/s11154-016-9347-2
   PubMed Web of Science ®Google Scholar
• Xu F, Zhao LH, Su JB, et al. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr. 2014;6(1):139. doi:10.1186/1758-5996-6-139
   PubMedGoogle Scholar
• American Diabetes Association. Diagnosis and classifcation of diabetes mellitus. Diabetes Care. 2011;34(Suppl 1):S62–S69. doi:10.2337/dc11-S062
   PubMed Web of Science ®Google Scholar
• Young MJ, Breddy JL, Veves A, et al. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care. 1994;17(6):557–560. doi:10.2337/diacare.17.6.557
   PubMed Web of Science ®Google Scholar
• Si H, Lei Z, Han C, et al. Evaluation of body surface area formulae for scaling GFR of adult renal patients: more between-subject variability explained by the DuBois & DuBois formula. Q J Nucl Med Mol Imaging. 2018;62(2):185–189. doi:10.23736/S1824-4785.16.02714-X
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi:10.1159/000180580
   PubMed Web of Science ®Google Scholar
• Iqbal Z, Azmi S, Yadav R, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 2018;40(6):828–849. doi:10.1016/j.clinthera.2018.04.001
   PubMed Web of Science ®Google Scholar
• Dominguez-Munoz FJ, Adsuar JC, Villafaina S, et al. Test-retest reliability of vibration perception threshold test in people with type 2 diabetes mellitus. Int J Environ Res Public Health. 2020;17(5):1. doi:10.3390/ijerph17051773
   Web of Science ®Google Scholar
• Brown JJ, Pribesh SL, Baskette KG, et al. A comparison of screening tools for the early detection of peripheral neuropathy in adults with and without type 2 diabetes. J Diabetes Res. 2017;2017:1467213. doi:10.1155/2017/1467213
   PubMed Web of Science ®Google Scholar
• Santos T, Melo JV, Leite NC, et al. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: results from the Rio de Janeiro type 2 diabetes cohort study. J Diabetes Complications. 2018;32(8):770–776. doi:10.1016/j.jdiacomp.2018.05.010
   PubMed Web of Science ®Google Scholar
• Willits I, Cole H, Jones R, et al. ViibraTip for testing vibration perception to detect diabetic peripheral neuropathy: a NICE medical technology guidance. Appl Health Econ Health Policy. 2015;13(4):315–324. doi:10.1007/s40258-015-0181-6
   PubMed Web of Science ®Google Scholar
• McIllhatton A, Lanting S, Lambkin D, et al. Reliability of recommended non-invasive chairside screening tests for diabetes-related peripheral neuropathy: a systematic review with meta-analyses. BMJ Open Diabetes Res Care. 2021;9(2):e002528. doi:10.1136/bmjdrc-2021-002528
   PubMed Web of Science ®Google Scholar
• Hu YM, Zhao LH, Zhang XL, et al. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients. Endocrine. 2018;60(2):292–300. doi:10.1007/s12020-018-1546-z
   PubMed Web of Science ®Google Scholar
• Yang J, Yang X, Zhao D, et al. Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy. J Diabetes Investig. 2021;12(5):828–836. doi:10.1111/jdi.13394
   PubMed Web of Science ®Google Scholar
• Abdelzaher LA, Imaizumi T, Suzuki T, et al. Astaxanthin alleviates oxidative stress insults-related derangements in human vascular endothelial cells exposed to glucose fluctuations. Life Sci. 2016;150:24–31. doi:10.1016/j.lfs.2016.02.087
   PubMed Web of Science ®Google Scholar
• Feldman EL, Nave KA, Jensen TS, et al. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron. 2017;93(6):1296–1313. doi:10.1016/j.neuron.2017.02.005
   PubMed Web of Science ®Google Scholar
• Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52(11):2795–2804. doi:10.2337/diabetes.52.11.2795
   PubMed Web of Science ®Google Scholar
• Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes. 1989;38(11):1456–1461. doi:10.2337/diab.38.11.1456
   PubMed Web of Science ®Google Scholar
• Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376(9739):419–430. doi:10.1016/S0140-6736(10)60576-4
   PubMed Web of Science ®Google Scholar
• Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig. 2017;8(5):646–655. doi:10.1111/jdi.12650
   PubMed Web of Science ®Google Scholar
• Liu J, Yuan X, Liu J, et al. Risk factors for diabetic peripheral neuropathy, peripheral artery disease, and foot deformity among the population with diabetes in Beijing, China: a Multicenter, Cross-Sectional Study. Front Endocrinol. 2022;13:824215. doi:10.3389/fendo.2022.824215
   PubMed Web of Science ®Google Scholar
• Jasti DB, Mallipeddi S, Apparao A, et al. A clinical and electrophysiological study of peripheral neuropathies in predialysis chronic kidney disease patients and relation of severity of peripheral neuropathy with degree of renal failure. J Neurosci Rural Pract. 2017;8(4):516–524. doi:10.4103/jnrp.jnrp_186_17
   PubMedGoogle Scholar
• Aggarwal HK, Sood S, Jain D, et al. Evaluation of spectrum of peripheral neuropathy in predialysis patients with chronic kidney disease. Ren Fail. 2013;35(10):1323–1329. doi:10.3109/0886022X.2013.828261
   PubMed Web of Science ®Google Scholar
• Doshi S, Moorthi RN, Fried LF, et al. Chronic kidney disease as a risk factor for peripheral nerve impairment in older adults: a longitudinal analysis of Health, Aging and Body Composition (Health ABC) study. PLoS One. 2020;15(12):e242406. doi:10.1371/journal.pone.0242406
   Web of Science ®Google Scholar
• Moorthi RN, Doshi S, Fried LF, et al. Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study. Nephrol Dial Transplant. 2019;34(4):625–632. doi:10.1093/ndt/gfy102
   PubMed Web of Science ®Google Scholar
• De Visser A, Hemming A, Yang C, et al. The adjuvant effect of hypertension upon diabetic peripheral neuropathy in experimental type 2 diabetes. Neurobiol Dis. 2014;62:18–30. doi:10.1016/j.nbd.2013.07.019
   PubMed Web of Science ®Google Scholar
• Jarmuzewska EA, Mangoni AA. Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes. J Intern Med. 2005;258(1):38–44. doi:10.1111/j.1365-2796.2005.01500.x
   PubMed Web of Science ®Google Scholar
• Moura NA, Zantut-Wittmann DE. Abnormalities of thyroid hormone metabolism during systemic illness: the low T3 syndrome in different clinical settings. Int J Endocrinol. 2016;2016:2157583. doi:10.1155/2016/2157583
   PubMed Web of Science ®Google Scholar
• Kong X, Wang J, Gao G, et al. Association between free thyroxine levels and diabetic retinopathy in euthyroid patients with type 2 diabetes mellitus. Endocr Res. 2020;45(2):111–118. doi:10.1080/07435800.2019.1690504
   PubMed Web of Science ®Google Scholar
• Lin J, Xiang X, Qin Y, et al. Correlation of thyroid-related hormones with vascular complications in type 2 diabetes patients with euthyroid. Front Endocrinol. 2022;13:1037969. doi:10.3389/fendo.2022.1037969
   PubMed Web of Science ®Google Scholar
• He W, Pang C, Chen L, et al. Low T3 syndrome is associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Muscle Nerve. 2022;66(6):723–729. doi:10.1002/mus.27719
   PubMed Web of Science ®Google Scholar
• Afarideh M, Aryan Z, Ghajar A, et al. Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes. Prim Care Diabetes. 2019;13(6):505–514. doi:10.1016/j.pcd.2019.03.009
   PubMed Web of Science ®Google Scholar
• Huang J, Li R, Liu N, et al. Liver fibrosis is independently associated with diabetic peripheral neuropathy in type 2 diabetes mellitus. J Diabetes Invest. 2021;12(11):2019–2027. doi:10.1111/jdi.13562
   PubMed Web of Science ®Google Scholar
• Mantovani A, Rigolon R, Mingolla L, et al. Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes. J Diabetes Complications. 2017;31(6):1021–1026. doi:10.1016/j.jdiacomp.2017.01.024
   PubMed Web of Science ®Google Scholar